Osimertinib-resistant NSCLC cells activate ERBB2 and YAP/TAZ and are killed by neratinib
| Autor: | Dent, Paul, Booth, Laurence, Poklepovic, Andrew, Von Hoff, Daniel, Martinez, Jennifer, Zhou, Yong, Hancock, John F. |
|---|---|
| Zdroj: | In Biochemical Pharmacology August 2021 190 |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|
Full Text from ScienceDirect